Lindahl advised Karolinska Development AB (publ), listed on Nasdaq Stockholm, in connection with its set-off issue directed to the company’s convertible holders, offering the convertible holders to set-off their convertibles as payment for new B-shares. The set-off issue was carried out to raise funds to reduce the company’s overall risk profile and ensure that the current cash resources can be used for new investments. A prospectus in respect of the set-off issue was made public on 17 March 2017.
Karolinska Development AB is an investment company focused on identifying medical innovation and investing in the creation and growth of companies developing these assets into differentiated products that will make a difference to patients' lives and provide an attractive return on investment.
Lindahl advised Karolinska Development AB through a team lead by Annika Andersson (Capital Markets and Public M&A), together with Olivia Toftgård, Anton Knifström, Pekka Frölander, Oliver Kronberg and Oscar Lunde (Capital Markets and Public M&A), Johan Hessius and Richard Perez (M&A), Jonas Löfgren (Life Science), Petter Larsson (Intellectual Property), Johan Hörnberg (Employment Law), and Anna Romell Stenmark and Therese Norenäs (Tax).
